Opportunity Information: Apply for CDC RFA GH15 1606
Apply for CDC RFA GH15 1606
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthen the Capacity of the Republic of Malis National Institute for Public Health Research (INRSP) to Implement Laboratory Based Activities and Research in Support of STI/HIV Prevention and Care Services under the Presidents Emergency Plan for AI" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Oct 3, 2014 and posted on Oct 3, 2014.
- Applicants must submit their applications by Dec 1, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The National Institute for Public Health Research (INRSP) is the only national institute within the Government of Mali that has been established for the purpose of conducting clinical and biological public health research. Since its creation in 1981, the INRSP has had a long history as a national laboratory with well established relations with local, regional, and international laboratories. The INRSP has the unique ability, responsibility, and experience to work with decentralized health centers throughout Mali to further develop the capacity of these centers by sustaining them with training and supervision on a regional and national scale. Additionally, since 1996 the INRSP has had a long history of collaboration with various divisions at the CDC, such as the STD Division, the Meningitis Division, the Neglected Tropical Diseases Division, Malaria Division, in addition to the Division of DGHA under PEPFAR. The INRSP is also a current partner of the Government of Mali National HIV AIDS Control Program (CSLS/MS) in implementing laboratory based STI HIV AIDS surveillance activities. Due to these factors, the INRSP is uniquely qualified to receive this award.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (CDC-RFA-GH15-1606) is a PEPFAR-supported cooperative agreement designed to strengthen Mali's National Institute for Public Health Research (INRSP) so it can more effectively carry out laboratory-based work and public health research that directly supports national STI and HIV prevention, treatment, and care services. The grant centers on targeted technical assistance that improves the quality, consistency, and strategic use of laboratory services and data within Mali's health system, with INRSP positioned as the national anchor institution for laboratory leadership and applied research.
The work described in the announcement focuses on several connected capacity-building priorities. A major component is strengthening quality control for laboratory services, which typically involves improving routine quality assurance practices, standard operating procedures, supervision and mentoring systems, and corrective-action processes that help laboratories deliver reliable test results. The opportunity also calls for revision of Mali's national STI/HIV testing and diagnostic algorithm, meaning the country would reassess and update how testing is sequenced and interpreted (for example, screening and confirmatory steps) so national guidance aligns with best practices, program needs, and available technologies. In parallel, the FOA emphasizes preparing Mali for laboratory accreditation processes, which generally requires structured readiness activities such as gap assessments, documentation systems, staff competencies, internal audits, and incremental quality improvement toward recognized standards.
Another key area is strengthening surveillance and strategic information by studying whether routine PMTCT (prevention of mother-to-child transmission) data can be feasibly used for ANC (antenatal care) surveillance. In practice, this kind of feasibility study examines whether data collected through routine service delivery are complete and reliable enough for surveillance purposes, whether they are representative, how they can be standardized, and what changes might be required in data collection tools, laboratory reporting, and data management workflows. The goal is to make better use of existing clinical and program data to inform national HIV planning and track trends, rather than relying only on specialized surveys.
The FOA also prioritizes human resources development at INRSP, including trainings and support for participation in international scientific conferences and symposiums. This reflects an intention to build lasting expertise within the institute by improving technical skills, strengthening scientific exchange, and increasing the ability of staff to design, conduct, analyze, and disseminate public health research that is relevant to Mali's HIV/STI response. In combination, these activities are meant to reinforce INRSP's role in supporting decentralized health centers across the country through training and supervision, thereby improving laboratory and surveillance performance beyond the capital and into regional and district levels.
From an administrative standpoint, this opportunity is a discretionary award using a cooperative agreement mechanism, meaning CDC would typically remain substantially involved through collaboration, guidance, and technical input as the recipient carries out the project. It falls under the health funding activity category and is tied to CFDA 93.067 (Global AIDS). The announcement anticipated a single award, with an award ceiling of $250,000, and it did not require cost sharing or matching. The opportunity was posted on October 3, 2014, with an original and final application deadline of December 1, 2014, and an archive date of December 31, 2014.
Eligibility is effectively limited to INRSP because the announcement describes it as the only national institute in Mali established specifically for clinical and biological public health research, with a long-standing mandate and track record as a national laboratory since 1981. The FOA highlights INRSP's established relationships with decentralized health centers and its history of collaboration with multiple CDC technical divisions, as well as its ongoing partnership with Mali's National HIV/AIDS Control Program in laboratory-based STI/HIV surveillance. These factors are presented as the rationale for why INRSP is uniquely qualified to carry out the technical assistance and capacity-building activities under this PEPFAR-supported effort.
For applicants or partners needing assistance accessing the full announcement, the notice provides CDC Procurement and Grants Office Technical Information Management Section contact details (pgotim@cdc.gov, 770-488-2700).
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a CDC funding announcement (CDC-RFA-GH15-1606) supported by PEPFAR. It is a cooperative agreement intended to strengthen Mali's National Institute for Public Health Research (INRSP) so it can more effectively conduct laboratory-based work and public health research that directly supports national STI and HIV prevention, treatment, and care services.
What is the main goal of the award?
The main goal is to improve the quality, consistency, and strategic use of laboratory services and laboratory-related data in Mali's health system, with INRSP serving as the national anchor institution for laboratory leadership and applied research that supports the national STI/HIV response.
What type of award mechanism is being used?
The announcement uses a cooperative agreement mechanism. This typically means CDC would have substantial involvement in the project through collaboration, guidance, and technical input while the recipient carries out the work.
Which program and funding category does this fall under?
It is listed under a health funding activity category and is tied to CFDA 93.067 (Global AIDS). The announcement is described as PEPFAR-supported.
What organizations are eligible to apply?
Eligibility is effectively limited to INRSP. The announcement presents INRSP as uniquely qualified because it is described as the only national institute in Mali established specifically for clinical and biological public health research, with a mandate and track record as a national laboratory since 1981.
Why does the announcement state INRSP is uniquely qualified?
The FOA cites INRSP's long-standing national role, its established relationships with decentralized health centers, its history of collaboration with multiple CDC technical divisions, and its ongoing partnership with Mali's National HIV/AIDS Control Program in laboratory-based STI/HIV surveillance.
How many awards were anticipated?
The announcement anticipated a single award.
What is the maximum (ceiling) funding amount?
The award ceiling listed in the announcement is $250,000.
Is cost sharing or matching required?
No. The announcement states that cost sharing or matching is not required.
What are the main technical focus areas described in the FOA?
The FOA focuses on connected capacity-building priorities, including strengthening laboratory quality control, revising Mali's national STI/HIV testing and diagnostic algorithm, preparing for laboratory accreditation processes, strengthening surveillance and strategic information through a feasibility study on using routine PMTCT data for ANC surveillance, and developing human resources at INRSP through training and participation in international scientific conferences and symposiums.
What does "strengthening quality control for laboratory services" mean in this context?
In the announcement, strengthening quality control is described in practical terms as improving routine quality assurance practices. This typically includes stronger standard operating procedures (SOPs), better supervision and mentoring systems, and corrective-action processes designed to help laboratories deliver reliable test results.
What is meant by revising the national STI/HIV testing and diagnostic algorithm?
It means Mali would reassess and update national guidance on how STI/HIV testing is sequenced and interpreted. The announcement references the idea of aligning screening and confirmatory steps with best practices, program needs, and available technologies.
What does preparing for laboratory accreditation involve?
The FOA frames accreditation preparation as structured readiness work. This generally includes gap assessments, documentation systems, staff competency strengthening, internal audits, and incremental quality improvements toward recognized standards.
What surveillance activity is highlighted in the announcement?
A key surveillance and strategic information priority is studying whether routine PMTCT (prevention of mother-to-child transmission) data can feasibly be used for ANC (antenatal care) surveillance.
What does the PMTCT-to-ANC surveillance feasibility study examine?
Based on the announcement, the feasibility study would examine whether routine service-delivery data are complete and reliable enough for surveillance, whether they are representative, how data could be standardized, and what changes might be needed in data collection tools, laboratory reporting, and data management workflows.
Why is the FOA interested in using routine PMTCT data for ANC surveillance?
The stated purpose is to make better use of existing clinical and program data to inform national HIV planning and track trends, rather than relying only on specialized surveys.
How does the FOA address workforce and institutional development at INRSP?
The FOA prioritizes human resources development through trainings and support for participation in international scientific conferences and symposiums, with the intent of building lasting expertise and improving the ability of staff to design, conduct, analyze, and disseminate public health research relevant to Mali's HIV/STI response.
Does the announcement mention support beyond the capital?
Yes. The activities are described as reinforcing INRSP's role in supporting decentralized health centers across the country through training and supervision, improving laboratory and surveillance performance at regional and district levels in addition to the capital.
What are the key dates for this opportunity?
The opportunity was posted on October 3, 2014. The original and final application deadline was December 1, 2014. The archive date was December 31, 2014.
Who can be contacted for help accessing the full announcement?
The notice provides CDC Procurement and Grants Office Technical Information Management Section contact details: pgotim@cdc.gov and 770-488-2700.
What is the relationship between CDC and the recipient under this cooperative agreement?
The announcement describes the mechanism as a cooperative agreement, which indicates CDC would typically remain substantially involved via collaboration, guidance, and technical input while the recipient implements the project activities.
What institution is intended to serve as Mali's national anchor for laboratory leadership under this award?
INRSP is positioned in the announcement as the national anchor institution for laboratory leadership and applied research supporting STI/HIV services and surveillance.
Browse more opportunities from the same category: Health
Next opportunity: Biology of the Temporomandibular Joint in Health and Disease (R21)
Previous opportunity: Biology of the Temporomandibular Joint in Health and Disease (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1606
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1606) also looked into and applied for these:
| Funding Opportunity |
|---|
| Biology of the Temporomandibular Joint in Health and Disease (R21) Apply for PA 14 359 Funding Number: PA 14 359 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Support the Ministry of Health (MOH) to Scale up and Improve HIV/AIDS Prevention, Care, and Treatment Services in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1547 Funding Number: CDC RFA GH15 1547 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Zambia DISCOVER H Apply for 611 DRAFT PROGRAM DESCRIPTION 001 Funding Number: 611 DRAFT PROGRAM DESCRIPTION 001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $60,000,000 |
| R40 Maternal and Child Health Research Program (MCHR) Apply for HRSA 15 062 Funding Number: HRSA 15 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 Maternal and Child Health Research Program (SDAS) Apply for HRSA 15 077 Funding Number: HRSA 15 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Service Area Competition Apply for HRSA 15 014 Funding Number: HRSA 15 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Hepatitis C Cooperative Research Centers Immunity to HCV Infection (U19) Apply for RFA AI 14 045 Funding Number: RFA AI 14 045 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| System Level Health Services and Policy Research on Health Disparities (R01) Apply for RFA MD 15 001 Funding Number: RFA MD 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NIMHD Academic Research Enhancement Award Enhancing Health Disparities Research at Undergraduate Institutions (R15) Apply for RFA MD 15 002 Funding Number: RFA MD 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 003 Funding Number: RFA MD 15 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Zambia Ministry of Healths Capacity to Provide Leadership to the National HIV/AIDS Response through Coordination, Policy Development, Mentorship and Training under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1600 Funding Number: CDC RFA GH15 1600 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,125,000 |
| Innovations for Healthy Living Improving Minority Health and Eliminating Health Disparities (R43) Apply for RFA MD 15 004 Funding Number: RFA MD 15 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp) Apply for PA 15 005 Funding Number: PA 15 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Vascular Dysfunction in the Pathogenesis of Severe Malaria (R01) Apply for RFA HL 15 023 Funding Number: RFA HL 15 023 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| IMPROVED SERVICES FOR VULNERABLE POPULATIONS (ISVP) Apply for RFA 696 14 000002 Funding Number: RFA 696 14 000002 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $37,000,000 |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for RFA NS 14 013 Funding Number: RFA NS 14 013 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Service Area Competition Apply for HRSA 15 015 Funding Number: HRSA 15 015 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33) Apply for RFA AI 14 062 Funding Number: RFA AI 14 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID Better Outcomes for Children Youth in Central Western Uganda Apply for RFA 617 14 000014 Funding Number: RFA 617 14 000014 Agency: Uganda USAID Kampala Category: Health Funding Amount: $38,500,000 |
| NIH Directors Early Independence Awards (DP5) Apply for RFA RM 14 004 Funding Number: RFA RM 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1606", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.